Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
Heineken warns that the growing use of weight‑loss drugs such as Wegovy could reduce beer demand in UK pubs. The Dutch brewer, the world’s second‑largest, notes that the appetite‑suppressing effects of these medications may lower alcohol consumption. It said the trend could hit sales of lagers and stouts, prompting the company to monitor market shifts.